Lumbar Interlaminar Epidural Steroid Injection
Clinical Documentation, Coverage Policy, Prior Authorization, Coding, Reimbursement, and Denial Prevention
GoHealthcare Results
REQUEST HELP
Request Help
GoHealthcare supports prior authorization, utilization management, clinical documentation, coding, revenue cycle operations, and denial prevention for musculoskeletal specialty practices. Visit https://www.gohealthcarellc.com/contact-us.html
Case Study Library
Review operational results and implementation examples at
How to Use This Resource
This page separates Medicare policy, commercial payer policy, delegated utilization management criteria, clinical evidence, and GoHealthcare operational guidance. Coverage rules change by payer, plan, state, employer group, benefit design, and delegated vendor. Verify the live policy and authorization pathway before every submission and again before the date of service.
- 1. Overview
- 2. Evidence at a Glance
- 3. Procedure Overview
- 4. Relevant Anatomy
- 5. Clinical Indications
- 6. Patient Selection
- 7. Contraindications and Precautions
- 8. Medical Necessity
- 9. Conservative Treatment Requirements
- 10. Diagnostic Prerequisites and Care-Pathway Sequencing
- 11. CMS National Coverage Determinations and National Guidance
- 12. Medicare LCDs and MAC Guidance
- 13. Medicare Billing and Coding Articles
- 14. CMS WISeR Model
- 15. Commercial Payer Policies
- 16. Blue Cross Blue Shield Policy Perspective
- 17. Delegated Utilization Management Guidelines
- 18. Evidence-Based Clinical and Specialty-Society Guidelines
- 19. Policy and Guideline Comparison Matrix
- 20. Prior Authorization Workflow
- 21. Clinical Documentation Requirements
- 22. Documentation Pearls
- 23. CPT and HCPCS Coding
- 24. ICD-10-CM Crosswalk
- 25. Modifiers, Units, NCCI, MUE, and Place of Service
- 26. Reimbursement Considerations
- 27. Integrated Compliance and Quality Controls
- 28. Denial Prevention
- 29. Common Denial Reasons
- 30. Appeals and Peer-to-Peer Review
- 31. Operational Workflow
- 32. Payer Perspective
- 33. Clinical Pearls
- 34. GoHealthcare Perspective
- 35. GoHealthcare Insights
- 36. Key Takeaways
- 37. Frequently Asked Questions
- 38. Related Procedures
- 39. References and Policy Sources
- 40. Disclaimer
1. Overview
A lumbar interlaminar epidural steroid injection (ILESI) delivers medication into the lumbar epidural space through an interlaminar approach. Operationally, the service is usually represented by CPT 62323 when imaging guidance is used and the injection is performed in the lumbar or sacral region. The procedure is most commonly evaluated for radicular pain or neurogenic claudication associated with disc herniation, degenerative narrowing, or other documented nerve-root irritation. It should not be treated as a generic injection for nonspecific axial low-back pain.
2. Evidence at a Glance
| Domain | Operational conclusion |
|---|---|
| Purpose | Short-term reduction of radicular pain or neurogenic claudication to improve function and facilitate rehabilitation when medically necessary. |
| Primary code | CPT 62323 for lumbar or sacral interlaminar epidural injection with imaging guidance; verify current CPT descriptors and payer edits. |
| Imaging | Fluoroscopy or CT with contrast is commonly required by Medicare LCDs and major payer criteria, absent a documented exception. |
| Frequency | Many Medicare LCDs and commercial criteria limit epidural sessions to four per spinal region in a rolling 12 months. |
| Repeat treatment | Usually requires documented meaningful pain relief and/or functional improvement, plus duration and response to the prior injection. |
| High-risk denial area | Requests for axial low-back pain without radiculopathy, unsupported level/region, inadequate conservative care, missing imaging concordance, or repeat injections without quantified outcomes. |
3. Procedure Overview
The interlaminar route enters the epidural space between adjacent laminae and generally produces broader epidural spread than a targeted transforaminal approach. The operational choice of route should be supported by the treating clinician's assessment, anatomy, symptom distribution, prior surgery, imaging, and treatment history. Payers may not require a comparative explanation in every case, but an unexplained route change after authorization is a common source of claim and authorization mismatch.
Operational distinctions
- Interlaminar injection: one lumbar or sacral regional injection per session under CPT 62323.
- Transforaminal injection: targeted nerve-root approach coded with 64483 and, when permitted, 64484.
- Caudal injection: enters through the sacral hiatus but is generally reported with the same lumbar/sacral interlaminar code family when imaging guidance is used.
- The approved authorization must match the performed approach, region, date range, units, rendering provider, and site of service.
4. Relevant Anatomy
The lumbar epidural space lies outside the dura and contains fat, venous structures, connective tissue, and traversing neural elements. Interlaminar access is typically selected at a lumbar interspace based on the pathology and intended cephalad or caudad spread. Prior decompression, fusion, epidural fibrosis, severe stenosis, anatomic variants, and implanted devices can alter access and medication distribution. These factors should be documented when they materially affect route selection or site of service.
5. Clinical Indications
- Lumbar radicular pain supported by history, examination, and concordant imaging or other diagnostic evidence.
- Neurogenic claudication associated with lumbar central or lateral recess stenosis when payer criteria are met.
- Persistent or recurrent radicular symptoms after lumbar surgery when scar, recurrent stenosis, or other pathology is documented and the requested route is clinically appropriate.
- Acute or subacute radicular pain severe enough to limit function or participation in conservative treatment, when the record supports payer-specific exceptions.
Many payer policies consider epidural steroid injection unsupported for isolated nonspecific axial low-back pain, widespread pain without a nerve-root pattern, or preventive use without current symptoms. Coverage language must be checked rather than inferred from clinical practice alone.
6. Patient Selection
| Selection element | Documentation expectation |
|---|---|
| Symptom pattern | Dermatomal or otherwise clinically coherent lower-extremity pain, sensory symptoms, weakness, or claudication. |
| Objective findings | Neurologic, tension-sign, gait, functional, or provocation findings appropriate to the diagnosis; document normal findings when relevant. |
| Diagnostic support | MRI or CT findings that explain the symptomatic region; explain clinical-imaging discrepancies. |
| Conservative care | Medication, activity modification, physical therapy or clinician-directed exercise, and other appropriate measures with dates and outcomes. |
| Functional impact | Specific limitations in walking, standing, sleep, work, self-care, rehabilitation, or activities of daily living. |
| Outcome plan | Baseline pain and function measures and a plan to evaluate pain relief, function, medication use, and duration. |
7. Contraindications and Precautions
- Uncontrolled infection or systemic sepsis.
- Uncorrected coagulopathy or anticoagulant management that does not meet current professional guidance and patient-specific risk assessment.
- Allergy to planned medication or contrast without an appropriate alternative plan.
- Progressive neurologic deficit or red-flag condition requiring urgent diagnostic or surgical evaluation rather than routine injection.
- Pregnancy or other circumstances in which radiation exposure requires additional justification and precautions.
- Uncontrolled diabetes, severe cardiopulmonary disease, immunosuppression, or other conditions requiring individualized risk mitigation.
8. Medical Necessity
Medical necessity is established by a coherent chain of evidence rather than a diagnosis code alone. The record should show a covered clinical syndrome, objective support, failed or insufficient conservative management, a reasonable expectation of benefit, and a plan to measure outcomes. Repeat injections require a new medical-necessity determination based on the prior response.
Core elements
- Pain or claudication of sufficient severity to impair function.
- Clinical findings consistent with lumbar or lumbosacral nerve-root irritation or stenosis.
- Diagnostic evidence concordant with the symptoms, when required.
- Appropriate nonoperative treatment completed, attempted, contraindicated, or not tolerated.
- No excluded indication or unresolved red flag.
- Requested code, route, region, and frequency within applicable policy limits.
9. Conservative Treatment Requirements
Policies vary in required duration and type of conservative care. Many expect at least four weeks of appropriate nonoperative treatment unless pain severity, neurologic findings, intolerance, or another documented circumstance supports earlier intervention. Avoid vague statements such as "failed conservative care." List the therapy, dates, adherence, response, and reason it was insufficient.
| Treatment | What the note should show |
|---|---|
| Medication management | Drug class, dates, tolerance, contraindication, and response. |
| Physical therapy or directed exercise | Start and end dates, attendance or adherence, functional response, and barriers. |
| Activity modification | What was modified and whether symptoms persisted. |
| Other nonoperative care | Chiropractic care, home exercise, education, or other appropriate interventions, with outcome. |
10. Diagnostic Prerequisites and Care-Pathway Sequencing
Imaging requirements
Most major policies expect recent or clinically relevant MRI or CT findings that support the symptomatic region. The report should be available to the authorization team, and the physician note should interpret the findings rather than merely paste the radiology impression. When imaging is unavailable, contraindicated, or discordant, explain the diagnostic basis and confirm whether the payer allows an exception.
Treatment sequencing
- Confirm that the request is therapeutic rather than a diagnostic selective nerve-root block.
- Check prior epidural procedures across all approaches in the same spinal region.
- Do not schedule the procedure until the approved code, route, provider, facility, dates, and units are confirmed.
- For repeat treatment, document the exact response and duration before submitting the next request.
11. CMS National Coverage Determinations and National Guidance
CMS does not maintain a single nationwide NCD that independently establishes all coverage criteria for lumbar interlaminar epidural steroid injections. Coverage is primarily governed through MAC LCDs, associated billing and coding articles, the Medicare Benefit Policy Manual, claims-processing rules, and general reasonable-and-necessary standards. Practices must identify the correct MAC jurisdiction and current policy version.
12. Medicare LCDs and MAC Guidance
Active MAC LCDs use substantially aligned criteria but can differ in covered diagnosis lists, effective dates, documentation language, and article structure. Common requirements include radicular pain or neurogenic claudication supported by history, examination, and imaging; meaningful functional impact; conservative treatment; image guidance with contrast; one spinal region per session; one interlaminar level per session; and no more than four epidural injection sessions per spinal region in a rolling 12-month period.
Common LCD requirements
- Use fluoroscopy or CT with contrast unless contrast is contraindicated and the exception is documented.
- Do not perform a predetermined series without evaluating response.
- Document at least 50% sustained improvement in pain and/or function for repeat treatment, using the governing LCD language.
- Use the lowest effective steroid dose.
- Avoid routine moderate or deep sedation unless separately justified.
- Treatment extending beyond 12 months generally requires additional justification and documentation.
| Representative source | Operational use |
|---|---|
| CMS LCD L36920 | Review current coverage indications, limitations, frequency, repeat-treatment, and documentation requirements. |
| CMS LCD L33906 | Review jurisdiction-specific effective version and associated coding article. |
| Other active MAC LCDs | Verify through the Medicare Coverage Database by patient location and date of service. |
13. Medicare Billing and Coding Articles
The billing and coding article paired with the governing LCD contains covered ICD-10-CM diagnoses, code-specific instructions, utilization parameters, and article-specific limitations. Examples include A56681, A56651, A58995, and other MAC-specific articles. The diagnosis list is not interchangeable across jurisdictions or permanent across policy versions.
- CPT 62323 represents lumbar or sacral interlaminar epidural injection with imaging guidance.
- The code is reported once per session; do not bill multiple interlaminar levels.
- Imaging guidance is included in the code and should not be separately reported.
- Confirm covered diagnoses in the article effective on the date of service.
- Verify modifier and place-of-service rules in current payer and Medicare edits.
14. CMS WISeR Model: Prior Authorization and Prepayment Review
The WISeR model introduces prior authorization or prepayment review for selected Original Medicare services in participating states and time periods. Code applicability and operational requirements can change. Verify the current CMS WISeR code list, state participation, submission pathway, decision status, and unique tracking requirements before scheduling. Do not assume that a traditional LCD-compliant request is exempt from model-specific review.
15. Commercial Payer Policies
Commercial policies often resemble Medicare but may impose different conservative-care durations, imaging requirements, frequency limits, outcome thresholds, site-of-service rules, and authorization vendors. UnitedHealthcare's current commercial medical policy addresses CPT 62323 and requires policy-specific medical-necessity criteria. Aetna, Cigna/Evernorth, Humana, employer plans, exchange products, and Medicaid products may apply separate documents or delegated criteria.
| Payer question | Verification point |
|---|---|
| Is prior authorization required? | Check payer, product, state, network, and delegated vendor. |
| Is interlaminar allowed for the diagnosis? | Confirm covered indication and exclusions. |
| What is the conservative-care threshold? | Verify duration, modalities, and exceptions. |
| What is required for repeat treatment? | Confirm relief percentage, functional improvement, and duration. |
| Are there site-of-service restrictions? | Confirm office, ASC, or hospital outpatient requirements. |
| Does authorization guarantee payment? | No. Eligibility, coding, medical necessity, claim edits, and benefit exclusions still apply. |
16. Blue Cross Blue Shield Policy Perspective
Blue Cross Blue Shield is not a single national medical policy for every member. Local Blues plans may publish their own policies or delegate review to Carelon, eviCore, Cohere, or another vendor. The member card, portal, product, state, and authorization response determine the controlling pathway. Avoid citing one Blues plan as universal authority for another plan.
17. Delegated Utilization Management Guidelines
Carelon
Carelon's current Interventional Pain Management guideline permits a lumbar interlaminar injection as one injection per session and generally limits therapeutic epidural injection sessions to four per spinal region in a rolling 12 months. Repeat treatment ordinarily requires at least 50% relief for at least three months, with a limited early second-injection pathway when the initial injection fails and a different approach, level, or steroid is used. Always verify the member-specific version and effective date.
eviCore by Evernorth
eviCore CMM-200 defines the interlaminar approach, requires clinical evidence of radicular pain or claudication, and applies plan-specific criteria for initial and repeat injections. The applicable guideline is determined by the health plan and effective date. Do not rely on a Cigna-specific or archived document for another delegated client.
Cohere Health
Cohere requirements are payer- and product-specific and are often implemented through a portal workflow rather than a single universal public policy. Confirm required questionnaires, attachment fields, code authorization, provider and facility selection, and approval dates in the live portal.
Evolent / RadMD
Evolent or RadMD criteria vary by contracted payer and program. Confirm whether the service is managed under interventional pain, advanced imaging, or another program; obtain the current clinical checklist; and verify that the authorization identifies CPT 62323, the correct provider, facility, region, and date range.
18. Evidence-Based Clinical and Specialty-Society Guidelines
Clinical evidence supports epidural steroid injections primarily for short-term improvement in selected patients with radicular pain, with more variable evidence for spinal stenosis and limited support for isolated axial low-back pain. Society recommendations and systematic reviews should inform clinical selection but do not replace payer coverage criteria. Evidence grade, outcome duration, injection route, steroid type, and population must be interpreted carefully.
- Use evidence to support appropriate selection and expected benefit, not to imply guaranteed outcomes.
- Do not present an insurer criterion as a universal clinical standard.
- Do not present a specialty-society recommendation as proof of coverage.
- Document shared decision-making, alternatives, and the intended functional goal.
19. Policy and Guideline Comparison Matrix
| Source type | Typical control point | Operational caution |
|---|---|---|
| Medicare LCD | Indication, imaging, frequency, repeat response, documentation | Confirm the patient-specific MAC and effective article. |
| Commercial medical policy | Covered indication, conservative care, repeat criteria, exclusions | Policy varies by product and state. |
| Carelon/eviCore/Evolent/Cohere | Delegated authorization workflow and clinical criteria | Vendor does not necessarily manage every member of the payer. |
| Clinical guideline | Evidence and professional recommendations | Does not create coverage or payment entitlement. |
| GoHealthcare insight | Workflow, documentation, quality control, denial prevention | Operational guidance; not payer policy or legal advice. |
20. Prior Authorization Workflow
- Verify active coverage, product, network, referral requirements, and authorization vendor.
- Confirm the requested service is lumbar interlaminar ESI and the code is CPT 62323.
- Review prior epidural injections across caudal, interlaminar, and transforaminal approaches in the same region.
- Validate diagnosis, symptom pattern, functional limitation, examination, and imaging concordance.
- Confirm conservative treatment and document dates, adherence, response, and exceptions.
- For repeat treatment, calculate pain relief, functional change, and duration from the prior injection.
- Submit the current office note, imaging report, therapy evidence, medication history, prior procedure report, and outcome data.
- Track the request until a written determination is received.
- Reconcile authorization details with scheduling and the planned site of service.
- Complete a pre-service final check and retain the approval in the permanent record.
21. Clinical Documentation Requirements
Initial request
- Chief complaint and onset.
- Lumbar or lumbosacral radicular distribution or neurogenic claudication.
- Pain score and specific functional limitations.
- Neurologic and musculoskeletal examination.
- Imaging date, level, and clinically relevant findings.
- Conservative treatment with dates and outcomes.
- Rationale for interlaminar route.
- Requested spinal region, code, and site of service.
- Risk review, planned follow-up, and measurable treatment goal.
Repeat request
- Prior procedure date, code, approach, and region.
- Baseline and post-procedure pain scores.
- Percentage of relief and duration.
- Specific functional improvement and duration.
- Medication reduction or improved participation in therapy, when applicable.
- Reason another injection is medically necessary now.
- Total epidural sessions in the region during the rolling 12 months.
22. Documentation Pearls
- Write "lumbar radicular pain" or "neurogenic claudication" only when the clinical record supports it.
- State the functional limitation in concrete terms, such as standing tolerance, walking distance, sleep disruption, or inability to participate in therapy.
- Link the MRI finding to the symptom pattern; do not paste the radiology report without interpretation.
- For conservative care, list dates and outcomes instead of "failed PT."
- For repeats, document percentage, function, and duration; "helped" is insufficient.
- If the route changes from transforaminal or caudal to interlaminar, explain why and obtain corrected authorization when necessary.
23. CPT and HCPCS Coding
| Code | Operational description | Key control |
|---|---|---|
| 62323 | Injection(s), diagnostic or therapeutic substance(s), including anesthetic, antispasmodic, opioid, steroid, other solution, into lumbar or sacral epidural space, interlaminar approach, with imaging guidance | Report once per session. Verify current official CPT wording and payer policy. |
| J-codes | Steroid or other separately payable drug code when allowed | Drug coding and units depend on product, dose, payer, and setting. |
| 77003/77012 | Imaging guidance codes | Do not separately report when imaging is included in CPT 62323. |
24. ICD-10-CM Crosswalk
The crosswalk is a documentation aid, not a guaranteed coverage list. Use the most specific diagnosis supported by the record and verify it against the patient's MAC billing article or commercial policy effective on the date of service.
| Clinical category | Illustrative ICD-10-CM families | Documentation caution |
|---|---|---|
| Lumbar radiculopathy | M54.16 | Document clinical radicular findings and laterality when relevant. |
| Lumbosacral radiculopathy | M54.17 | Use only when the lumbosacral diagnosis is supported. |
| Lumbar disc disorder with radiculopathy | M51.16 family | Confirm current code specificity and imaging concordance. |
| Lumbosacral disc disorder with radiculopathy | M51.17 family | Confirm current code specificity. |
| Lumbar spinal stenosis with neurogenic claudication | M48.062 | Document walking/standing limitation and claudication pattern. |
| Postlaminectomy syndrome | M96.1 | Do not assume coverage without active radicular symptoms and policy support. |
25. Modifiers, Units, NCCI, MUE, and Place of Service
- Report CPT 62323 as one unit unless the payer's published instructions state otherwise.
- Do not append bilateral modifiers to create additional units for an interlaminar injection.
- Verify professional and facility claim rules for office, ASC, and hospital outpatient settings.
- Review current NCCI edits before separately reporting related services.
- Imaging guidance is bundled into CPT 62323.
- Routine moderate sedation may be noncovered or separately denied unless medically necessary and documented.
- Drug units must match the exact product, dose, code descriptor, and payer rules.
26. Reimbursement Considerations
Payment depends on payer contract, setting, professional/facility split, drug billing, status indicators, bundling edits, and geographic adjustments. Authorization is not a payment guarantee. Before service, confirm eligibility, network status, referral, authorization, benefits, deductible/coinsurance, site-of-service requirements, and whether the drug is separately reimbursable. After service, reconcile the procedure report, charge entry, authorization, claim, and remittance.
27. Integrated Compliance and Quality Controls
| Control point | Required check |
|---|---|
| Intake | Payer, product, vendor, network, referral, benefits. |
| Clinical review | Diagnosis, symptom pattern, examination, imaging, conservative care. |
| Utilization review | Prior epidural sessions, response, rolling 12-month frequency. |
| Authorization | Code 62323, provider, facility, dates, units, region. |
| Scheduling | Approval attached and procedure plan matches authorization. |
| Charge capture | Procedure report supports code, drug, units, modifiers, and POS. |
| Denial monitoring | Root cause categorized and corrected at workflow level. |
28. Denial Prevention
- Do not submit before identifying the correct authorization vendor.
- Do not use a diagnosis code unsupported by the narrative and imaging.
- Do not omit prior injection dates or outcomes.
- Do not request a series of injections in advance.
- Do not schedule outside the authorization date range or at an unapproved facility.
- Do not change approach on the procedure date without authorization reconciliation.
- Do not separately bill bundled imaging guidance.
29. Common Denial Reasons
| Denial reason | Prevention |
|---|---|
| No radiculopathy or claudication documented | Use a coherent symptom, exam, and imaging narrative. |
| Insufficient conservative care | Provide dates, modalities, response, and exception rationale. |
| Imaging not concordant | Explain the clinical correlation or obtain additional diagnostic clarification. |
| Frequency exceeded | Count all epidural approaches in the same spinal region. |
| Repeat response not established | Document percentage relief, function, and duration. |
| Authorization mismatch | Reconcile code, route, provider, facility, dates, and units before service. |
| Bundled imaging billed separately | Apply CPT and NCCI rules at charge entry. |
30. Appeals and Peer-to-Peer Review
Appeal structure
- Identify the exact denial rationale and controlling policy version.
- State the covered clinical syndrome and functional impairment.
- Summarize examination and imaging concordance.
- List conservative treatment with dates and outcomes.
- For repeats, quantify prior pain and functional response and duration.
- Explain why lumbar interlaminar access is appropriate.
- Address every cited criterion and attach the underlying evidence.
Peer-to-peer preparation card
- Requested code: 62323.
- Diagnosis and symptom distribution.
- Key objective findings.
- Imaging level and date.
- Conservative treatment dates and response.
- Prior epidural history and outcomes.
- Requested site of service and clinical reason.
- Policy clause being disputed.
31. Operational Workflow
The optimal workflow is a closed-loop process: referral or order intake, benefit and authorization-pathway verification, clinical packet review, submission, follow-up, decision capture, scheduling reconciliation, pre-service validation, charge review, claim monitoring, and outcome documentation. Ownership must be explicit at each handoff. A missing approval, wrong facility, or undocumented prior response is an operational defect, not merely a payer problem.
32. Payer Perspective
Payers evaluate whether the service is targeted to a covered radicular or claudication syndrome, whether conservative care and diagnostic evidence support escalation, whether frequency is reasonable, and whether prior treatment produced measurable benefit. The strongest request makes those elements visible without requiring the reviewer to reconstruct the case from unrelated notes.
33. Clinical Pearls
- Select the route based on patient-specific anatomy and treatment goals, not habit or authorization convenience.
- Use imaging guidance and contrast in accordance with policy and clinical safety standards.
- Reassess new weakness, bowel or bladder symptoms, fever, trauma, or rapidly progressive symptoms before proceeding.
- Use the lowest effective steroid dose and document medication selection.
- Measure function as well as pain; functional response often determines repeat authorization.
34. GoHealthcare Perspective
Lumbar interlaminar ESI is frequently denied not because the procedure is inherently noncovered, but because the clinical and operational record is fragmented. High-performing practices standardize the intake checklist, payer pathway, clinical packet, prior-injection inventory, outcome measurement, scheduling reconciliation, and charge audit. The goal is a defensible episode of care from order through remittance.
35. GoHealthcare Insights
- Treat every repeat injection as a new medical-necessity review.
- Build a regional epidural utilization ledger across caudal, interlaminar, and transforaminal approaches.
- Use a structured outcome template that captures pain percentage, function, duration, medication use, and rehabilitation progress.
- Place the approved authorization next to the procedure order and charge ticket.
- Audit route changes and site-of-service changes before the date of service.
- Use denial root-cause data to revise templates and staff training.
36. Key Takeaways
- CPT 62323 is the principal code for lumbar or sacral interlaminar ESI with imaging guidance.
- A covered diagnosis code alone does not establish medical necessity.
- Medicare coverage is primarily controlled by MAC LCDs and billing articles, not a single national NCD.
- Commercial and delegated criteria vary by member and product.
- Repeat treatment requires quantified outcome documentation.
- Authorization details must match the performed service.
- The strongest denial-prevention strategy is a standardized, closed-loop workflow.
37. Frequently Asked Questions
What code is generally used for lumbar interlaminar ESI?
CPT 62323 when the service is performed in the lumbar or sacral region with imaging guidance. Verify the current CPT manual and payer policy.
Can CPT 62323 be billed for more than one interlaminar level?
It is generally reported once per session. Medicare billing articles commonly state that 62323 may be reported for only one level per session.
Is fluoroscopy separately billable?
No. Imaging guidance is included in CPT 62323.
Can 62323 be billed bilaterally?
The interlaminar injection is not coded as a bilateral service merely because symptoms are bilateral. Do not use modifiers to create extra units without payer authority.
Is lumbar interlaminar ESI covered for axial low-back pain?
Many policies do not cover epidural steroid injection for isolated nonspecific axial pain without radiculopathy or claudication.
Is an MRI required?
Most policies expect imaging that supports the symptomatic region, but exact requirements and exceptions vary. Verify the controlling policy.
How many sessions are allowed?
Many Medicare LCDs and commercial criteria limit epidural injection sessions to four per spinal region in a rolling 12 months.
Do transforaminal and caudal injections count toward the same frequency limit?
Often yes, because the limit applies to all epidural injection sessions in the same spinal region. Verify the policy.
What is required for a repeat injection?
Typically documented meaningful pain relief and/or functional improvement, duration of benefit, and continued medical necessity.
Can authorization be transferred to another facility?
Not automatically. Many approvals are provider- and facility-specific. Obtain a corrected authorization before service.
Does authorization guarantee payment?
No. Coverage, eligibility, coding, claim edits, network status, and benefit limitations still apply.
What is the most preventable denial?
An authorization or documentation mismatch, especially missing prior-response data or a performed route that differs from the approved service.
38. Related Procedures
- Caudal Epidural Steroid Injection
- Lumbar Transforaminal Epidural Steroid Injection
- Cervical Interlaminar Epidural Steroid Injection
- Thoracic Interlaminar Epidural Steroid Injection
- Sacral Transforaminal Epidural Steroid Injection
GoHealthcare Case Study Library
39. References and Policy Sources
- CMS Medicare Coverage Database - LCD L36920: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=36920
- CMS Medicare Coverage Database - LCD L33906: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdId=33906
- CMS Billing and Coding Article A56681: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56681
- CMS Billing and Coding Article A56651: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56651
- CMS Billing and Coding Article A58995: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=58995
- UnitedHealthcare - Epidural Steroid Injections for Spinal Pain: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/epidural-steroid-injections-spinal-pain.pdf
- Carelon - Interventional Pain Management Guidelines: https://guidelines.carelonmedicalbenefitsmanagement.com/interventional-pain-management-2026-06-14/
- eviCore - CMM-200 Epidural Steroid Injections: https://www.evicore.com/sites/default/files/clinical-guidelines/2026-04/Cigna_CMM-200%20Epidural%20Steroid%20Inj_V1.0.2026_Eff08.04.2026_Pub04.17.2026.pdf
- GoHealthcare Case Study Library: https://www.gohealthcarellc.com/case-studies.html
- GoHealthcare Request Help: https://www.gohealthcarellc.com/contact-us.html
40. Disclaimer
This resource is educational and operational in nature. It is not medical advice, legal advice, coding advice, a guarantee of coverage, or a substitute for the current CPT manual, ICD-10-CM code set, CMS regulations, MAC policies, payer contracts, medical policies, utilization management criteria, clinical judgment, or compliance counsel. Policies, codes, edits, and reimbursement rules change. Verify all requirements using the member-specific plan, live payer portal, current Medicare Coverage Database, and official code sets before authorization, scheduling, billing, or appeal activity.
Request Help
Request Help
GoHealthcare Practice Solutions supports musculoskeletal specialty practices with prior authorization, utilization management, documentation improvement, coding and revenue cycle operations, and denial prevention. Visit https://www.gohealthcarellc.com/contact-us.html
See Our Results
Explore the GoHealthcare Case Study Library